| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18550874 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 128 journal articles in the PubMed database | Email to a friend | | |
| Ehrlich HJ, Müller M, Oh HM, et al.
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. [Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2008 Jun 12; 358(24):2573-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nolan TM, Richmond PC, Skeljo MV, et al.
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. [JOURNAL ARTICLE]
Vaccine 2008 Jun 13.
Abstract | Full Citation | Find Related Articles | | Leroux-Roels I, Borkowski A, Vanwolleghem T, et al.
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2007 Aug 18; 370(9587):580-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Levie K, Leroux-Roels I, Hoppenbrouwers K, et al.
An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. [JOURNAL ARTICLE]
J Infect Dis 2008 Jun 24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lin J, Zhang J, Dong X, et al.
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. [Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial]
Lancet 2006 Sep 16; 368(9540):991-7.
Abstract | Full Citation | Find Related Articles | | Treanor JJ, Campbell JD, Zangwill KM, et al.
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. [Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2006 Mar 30; 354(13):1343-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bresson JL, Perronne C, Launay O, et al.
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. [Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial]
Lancet 2006 May 20; 367(9523):1657-64.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bernstein DI, Edwards KM, Dekker CL, et al.
Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults. [JOURNAL ARTICLE]
J Infect Dis 2008 Feb 8.
Abstract | Full Citation | Find Related Articles | | Leroux-Roels I, Bernhard R, Gérard P, et al.
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine. [Journal Article]
PLoS ONE 2008; 3(2):e1665.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
